Alnylam Pharmaceuticals
ALNY
#571
Rank
โ‚ฌ36.04 B
Marketcap
271,80ย โ‚ฌ
Share price
-1.80%
Change (1 day)
22.05%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company